Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$24.7 - $37.61 $183,125 - $278,840
-7,414 Reduced 11.09%
59,411 $1.5 Million
Q1 2023

May 09, 2023

SELL
$18.36 - $35.27 $2.09 Million - $4.01 Million
-113,829 Reduced 63.01%
66,825 $2.15 Million
Q4 2022

Feb 14, 2023

SELL
$18.32 - $30.66 $205,440 - $343,821
-11,214 Reduced 5.84%
180,654 $3.33 Million
Q3 2022

Nov 10, 2022

BUY
$14.33 - $28.47 $826,554 - $1.64 Million
57,680 Added 42.98%
191,868 $5.18 Million
Q2 2022

Aug 11, 2022

SELL
$11.52 - $20.4 $485,544 - $859,819
-42,148 Reduced 23.9%
134,188 $1.85 Million
Q1 2022

May 13, 2022

SELL
$12.36 - $20.31 $892,354 - $1.47 Million
-72,197 Reduced 29.05%
176,336 $3.44 Million
Q4 2021

Feb 11, 2022

BUY
$12.46 - $27.87 $1.01 Million - $2.27 Million
81,342 Added 48.65%
248,533 $4.06 Million
Q3 2021

Nov 12, 2021

BUY
$25.78 - $33.21 $321,631 - $414,327
12,476 Added 8.06%
167,191 $4.66 Million
Q2 2021

Aug 12, 2021

BUY
$26.8 - $31.84 $126,013 - $149,711
4,702 Added 3.13%
154,715 $4.59 Million
Q1 2021

May 14, 2021

BUY
$24.03 - $29.97 $1.46 Million - $1.82 Million
60,665 Added 67.9%
150,013 $4.19 Million
Q4 2020

Feb 10, 2021

BUY
$23.41 - $28.34 $2.09 Million - $2.53 Million
89,348 New
89,348 $2.53 Million

Others Institutions Holding RVNC

About Revance Therapeutics, Inc.


  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Evolutionary Tree Capital Management, LLC Portfolio

Follow Evolutionary Tree Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolutionary Tree Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evolutionary Tree Capital Management, LLC with notifications on news.